These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 228904)

  • 41. Eradication of Aujeszky's disease virus from a Swedish pig herd using gI-/TK-vaccine.
    Engel M; Wierup M
    Vet Rec; 1997 May; 140(19):493-5. PubMed ID: 9172294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination strategies for improving the efficacy of programs to eradicate Aujeszky's disease virus.
    Visser N
    Vet Microbiol; 1997 Apr; 55(1-4):61-74. PubMed ID: 9220597
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of an intranasal immunization with gEgC and gEgI double-deletion mutants of Aujeszky's disease virus in maternally immune pigs and the effects of a successive intramuscular booster with commercial vaccines.
    Nauwynck HJ; Labarque GG; Pensaert MB
    Zentralbl Veterinarmed B; 1999 Dec; 46(10):713-22. PubMed ID: 10676150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Control of Aujeszky's disease.
    Kit S; Sheppard M; Kit M
    Vet Rec; 1986 Mar; 118(11):310. PubMed ID: 3010537
    [No Abstract]   [Full Text] [Related]  

  • 45. Intranasal vaccination of pigs against Aujeszky's disease. 4. Comparison with one or two doses of an inactivated vaccine in pigs with moderate maternal antibody titres.
    Van Oirschot JT; De Leeuw PW
    Vet Microbiol; 1985 Aug; 10(5):401-8. PubMed ID: 2996212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virological protection of sows upon challenge with Aujeszky's disease virus after multiple vaccinations with attenuated or inactivated vaccines.
    Nauwynck HJ; Zonnekeyn V; Pensaert MB
    Zentralbl Veterinarmed B; 1997 Dec; 44(10):609-15. PubMed ID: 9467303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunizing properties of 3 vaccines against Aujeszky's disease].
    Zuffa A; Salaj J; Zuffa T; Pytlik F; Zajac J
    Arch Exp Veterinarmed; 1984 Mar; 38(2):258-67. PubMed ID: 6331335
    [No Abstract]   [Full Text] [Related]  

  • 48. Vaccination of pigs against Aujeszky's disease by the intradermal route using live attenuated and inactivated virus vaccines.
    Vannier P; Cariolet R
    Zentralbl Veterinarmed B; 1989 Sep; 36(7):515-26. PubMed ID: 2554623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of antibodies of field pseudorabies virus in pigs of herd vaccinated with live vaccine.
    Asai T; Tajima M; Watanabe H; Shibata I
    J Vet Med Sci; 1998 Mar; 60(3):399-400. PubMed ID: 9560796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vaccination of piglets of different ages with inactivated Aujeszky's disease vaccine].
    Jakubik J; Wittmann G
    Berl Munch Tierarztl Wochenschr; 1979 Sep; 92(17):343-5. PubMed ID: 231429
    [No Abstract]   [Full Text] [Related]  

  • 51. [Field experience using an inactivated vaccine in Aujeszky's disease vaccination of cattle (author's transl)].
    Rigter IA; van Lom HB; de Leeuw PW; van Walsem B; Overgoor GH
    Tijdschr Diergeneeskd; 1981 Oct; 106(19):993-5. PubMed ID: 6270844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Control of latent enzootic Aujeszky's disease].
    Motovski A; Iordanov S
    Vet Med Nauki; 1982; 19(3):35-8. PubMed ID: 6291226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Challenge experiments with the virus of Aujeszky's disease in non-vaccinated and vaccinated sheep.
    Rondhuis PR; Wirahadiredja RM; Akkermans JP; Jakubik J
    Zentralbl Veterinarmed B; 1978 Jan; 25(1):70-80. PubMed ID: 207055
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of Aujeszky's disease in a pig breeding farm].
    van Golstein Brouwers GW
    Tijdschr Diergeneeskd; 1979 Nov; 104(21):832-3. PubMed ID: 229584
    [No Abstract]   [Full Text] [Related]  

  • 55. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines.
    Vannier P; Hutet E; Bourgueil E; Cariolet R
    Vet Microbiol; 1991 Nov; 29(3-4):213-23. PubMed ID: 1663287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines.
    Pensaert MB; De Smet K; De Waele K
    Vet Microbiol; 1990 Apr; 22(2-3):107-17. PubMed ID: 2162094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Colostral immunity and immunoprophylaxis in Aujeszky's disease].
    Motovski A
    Vet Med Nauki; 1978; 15(9):12-20. PubMed ID: 88789
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of vaccination on shedding of Aujeszky's disease virus in experimentally infected pigs and role of vaccination in herd health programmes.
    Smíd B; Rodák L; Valícek L; Sabo A; Matis J
    Acta Vet Hung; 1994; 42(2-3):391-6. PubMed ID: 7810436
    [No Abstract]   [Full Text] [Related]  

  • 59. Aujeszky's disease and the European Community.
    Moynagh J
    Vet Microbiol; 1997 Apr; 55(1-4):159-66. PubMed ID: 9220609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines.
    Peeters B; Bouma A; de Bruin T; Moormann R; Gielkens A; Kimman T
    Vaccine; 1994 Mar; 12(4):375-80. PubMed ID: 8178562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.